Anthracyclines have been important and effective treatments against a number of cancers
since their discovery. However, their use in therapy has been complicated by severe side …

This paper provides a review of the literature on the use of Pluronic® triblock copolymers for
drug encapsulation over the last 10 years. A special focus is given to the progress of drug …

As traditional strategies for cancer treatment, some chemotherapy agents, such as
doxorubicin, oxaliplatin, cyclophosphamide, bortezomib, and paclitaxel exert their anti-tumor …

The importance of drugs is well known, and researches on aspects of drugs have aroused
widespread concern. Molecularly imprinted polymers (MIPs) have the high affinity as well as …

Anthracycline-induced cardiotoxicity (AIC) is a serious and common side effect of
anthracycline therapy. Identification of genes and genetic variants associated with AIC risk …

Cardiotoxicity is the main side effect of several chemotherapeutic drugs. Doxorubicin (Doxo)
is one of the most used anthracyclines in the treatment of many tumors, but the development …

The pharmaceutical sector has made considerable strides recently, emphasizing improving
drug delivery methods to increase the bioavailability of various drugs. When used as a …

Neoadjuvant and adjuvant therapies have made significant progress in cancer treatment.
However, tumor adjuvant therapy still faces challenges due to the intrinsic heterogeneity of …

Nano-structured and functionalized materials for encapsulation, transport, targeting and
controlled release of drugs are of high interest to overcome low bioavailability in oral …

Glioblastoma (GBM) is the most common lethal brain tumor with dismal treatment outcomes
and poor response to chemotherapy. As the regulatory center of cytogenetics and …